Early-stage pancreatic cancer outcomes hinge on lymph node counts, affecting surgical decisions.
- Optimal examined lymph nodes for best survival in stage I and II is ≥10.
- Stage II patients benefit most with ≥12 examined lymph nodes; ≥7 for T3N0M0 cases.
- An examined lymph node to regional node positive ratio of ≥9 leads to optimal survival in these patients.
Surgeons should prioritize achieving these lymph node thresholds to enhance patient prognoses.
Journal Article by Xu H, Huang H (…) Huang G et 6 al. in Front Surg
© 2025 Xu, Huang, Yan, Li, Xiao, Wang, Wang, Ge and Huang.